Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
16Feb
Related Posts
02May
Our research is aimed at making treatment for rare genetic diseases affordable
In an exclusive interview to Gunjan Sharma from the HealthPost, Dr. Rakesh... read more
26Aug
Technical Advisory Committee recommends sewage surveillance for early detection of Mpox in Karnataka
In a recently held meeting, the State Technical Advisory Committee (STAC) on... read more
02Mar
This discovery of 29 ‘new’ mosquito genes could open door to curbing malaria spread in India
A comprehensive genome sequencing of a Anopheles stephensi — a malaria-carrying mosquito found in... read more
11Jul
TIGS scientists present their work at International conference on Genetics and Genomics in Health and Diseases
Scientists from TIGS presented their work at the recently concluded 8th Annual... read more
08Jun
Environmental Surveillance and One Health Take Center Stage at CSIR-NEERI World Environment Day Event
A timely reminder that environmental surveillance is becoming a critical pillar of... read more
09Apr
Interview with Dr.Rakesh Mishra on IndiaScience TV
How dangerous is the new XE variant of Covid-19? Is the Covid... read more
07Mar
TIGS visit to TATA Digital Nerve Centre (DiNC), Kolar
TIGS scientists recently visited the Tata Digital Nerve Centre at Kolar, Karnataka.... read more
16Dec
India must scale up wastewater analysis for health surveillance
In this latest opinion piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS... read more
03Jun
Karnataka launches antimicrobial resistance surveillance programme in collaboration with TIGS – The Hindu
Antimicrobial Resistance (AMR) is one of the most pressing public health challenges... read more